pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
raps·Jul 27·1 min read
save

Australia's TGA adopts 23 international scientific guidelines from EMA, ICH and FDA

Jul 27, 2026·read at raps ↗RegulatoryNeutral

The Therapeutic Goods Administration (TGA) in Australia announced it has formally adopted 23 scientific guidelines.

The guidelines come from the European Medicines Agency, the International Council for Harmonisation, and the U.S. Food and Drug Administration, aligning Australian regulatory practices with global standards.

The move is expected to streamline drug development and approval processes in Australia, facilitating greater international collaboration and potentially accelerating patient access to new therapies.

source

This writeup was produced by pharmadog from original reporting by raps.

Original headline: “Asia-Pacific Roundup: TGA adopts 23 international scientific guidelines”

read at raps ↗
96 words · retrieved Jul 27
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
ApprovalPain

related stories

  • 3d agoTScan axes 75% of workforce, prioritizes solid tumor programBioSpace
  • Aug 10BlossomHill, Latigo bloom on Nasdaq with oversubscribed IPOsBioSpace
  • Jul 24This Week at FDA: Diamantas touts onshoring efforts, grants for DHTs, and moreraps
  • Jul 23FDA panel confronting peptide controversySTAT
  • Jul 22Crystalys nets $130M more to push gout drug through late-stage testsBioPharma Dive